Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Lipoprotein(a)

E-BookPDF1 - PDF WatermarkE-Book
443 Seiten
Englisch
Springer International Publishingerschienen am03.03.20232023
Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease.  Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovascular events compared to people with low Lp(a) levels. Despite this risk, awareness of Lp(a) is still very low among health care providers. Even cardiologists often overlook Lp(a), in part because Lp(a) is not as well-understood as other risk factors and treatment options are still very limited. 
 

This book offers an authoritative and comprehensive overview of Lipoprotein(a). It provides an in-depth review of all aspects of Lp(a), from pathophysiology to metabolism. Chapters offer the reader a contemporary view of the important roles of Lp(a) as a risk factor for cardiovascular disease. In addition, this volume discusses the clinical implications of elevated Lp(a) and current and future therapies. 

 

Lipoprotein(a) is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.





Karam Kostner, MD, Ph.D., FRACP,  FCSANZ

Associate Professor of Medicine



University of Queensland and Mater Hospital
Brisbane, Australia










Gerhard M. Kostner, Ph.D.

Emeritus Professor of Biochemistry and Molecular Biology



Medical University of Graz, Austria

Graz, Austria







Peter P. Toth, M.D. , PhD, FAHA, FESC, FACC

Adjunct Professor of Medicine



Division of Cardiology


Johns Hopkins University School of Medicine

Baltimore, Maryland  USA
mehr
Verfügbare Formate
BuchGebunden
EUR235,39
E-BookPDF1 - PDF WatermarkE-Book
EUR223,63

Produkt

KlappentextLipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease.  Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovascular events compared to people with low Lp(a) levels. Despite this risk, awareness of Lp(a) is still very low among health care providers. Even cardiologists often overlook Lp(a), in part because Lp(a) is not as well-understood as other risk factors and treatment options are still very limited. 
 

This book offers an authoritative and comprehensive overview of Lipoprotein(a). It provides an in-depth review of all aspects of Lp(a), from pathophysiology to metabolism. Chapters offer the reader a contemporary view of the important roles of Lp(a) as a risk factor for cardiovascular disease. In addition, this volume discusses the clinical implications of elevated Lp(a) and current and future therapies. 

 

Lipoprotein(a) is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.





Karam Kostner, MD, Ph.D., FRACP,  FCSANZ

Associate Professor of Medicine



University of Queensland and Mater Hospital
Brisbane, Australia










Gerhard M. Kostner, Ph.D.

Emeritus Professor of Biochemistry and Molecular Biology



Medical University of Graz, Austria

Graz, Austria







Peter P. Toth, M.D. , PhD, FAHA, FESC, FACC

Adjunct Professor of Medicine



Division of Cardiology


Johns Hopkins University School of Medicine

Baltimore, Maryland  USA
Details
Weitere ISBN/GTIN9783031245756
ProduktartE-Book
EinbandartE-Book
FormatPDF
Format Hinweis1 - PDF Watermark
FormatE107
Erscheinungsjahr2023
Erscheinungsdatum03.03.2023
Auflage2023
Seiten443 Seiten
SpracheEnglisch
IllustrationenXVII, 443 p. 92 illus., 76 illus. in color.
Artikel-Nr.10360122
Rubriken
Genre9200

Inhalt/Kritik

Inhaltsverzeichnis
60 years of Lp(a) research-From Ouchterlonys double diffusion to a significant risk factor for CHD.- Lp(a) structure and composition.- Genetics of Lipoprotein(a).- Lp(a) metabolism.- Contemporary aspects of Lp(a) metabolism and therapies based on tracer kinetic methods.- Role of Proprotein Convertase Subtilisin Kexin type 9 in Lipoprotein(a) Metabolism.- The Role of Cell Surface Receptors in Lp(a) Metabolism.- Physiological Roles And Functions Of Lipoprotein(a).- The role of Lp(a) in Atherosclerosis: An overview.- Role of macrophages in Lp(a) pathophysiology.- Thrombosis, Inflammation and Lipoprotein(a): Clinical Implications .- The role of the kidney in Lp(a) physiology and pathophysiology.- Lp(a) as a cardiovascular risk factor.- Lp(a) and aortic valve stenosis, stroke, and other non-coronary cardiovascular diseases.- Lp(a) in cardiovascular disease: Evidence from Large Epidemiological Studies.- Lipoprotein(A) And Immunity.- When to measure Lp(a) .- Measurement of Lipoprotein (a) in the Clinical Laboratory.- Standardization of analytical methods for the measurement of Lipoprotein(a): bridging past and future initiatives.- Establishing an SI-traceable Reference Measurement System for Lp(a), based on Quantitative Protein Mass Spectrometry and Molar Units.- Compounds that impact Lp(a) concentrations.- Antisense oligonucleotide therapy to treat elevated lipoprotein(a).- Lipoprotein apheresis for reduction of Lipoprotein(a).- Elevated Lp(a) - Why Should I Test For It, If I Cannot Treat It? A Patient's Perspective .- Burning unanswered questions Therapy.mehr

Autor

Karam Kostner, MD, Ph.D., FRACP, FCSANZ

Associate Professor of Medicine



University of Queensland and Mater Hospital
Brisbane, Australia








Gerhard M. Kostner, Ph.D.

Emeritus Professor of Biochemistry and Molecular Biology



Medical University of Graz, Austria
Graz, Austria





Peter P. Toth, M.D. , PhD, FAHA, FESC, FACC

Adjunct Professor of Medicine



Division of Cardiology


Johns Hopkins University School of Medicine

Baltimore, Maryland USA